Alessandro Zerbi

Summary

Affiliation: Istituto Clinico Humanitas
Country: Italy

Publications

  1. doi request reprint Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases
    Alessandro Zerbi
    Pancreatic Surgery Section, Humanitas Scientific Institute, Via Manzoni 56, Rozzano, Milan, Italy
    Langenbecks Arch Surg 396:313-21. 2011
  2. doi request reprint Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial
    Michele Reni
    Department of Oncology, S Raffaele Scientific Institute, Milan, Italy
    Ann Surg Oncol 19:2256-63. 2012
  3. ncbi request reprint Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma
    Michele Reni
    Department of Radiochemotherapy, S Raffaele H Scientific Institute, Milan, Italy
    Oncology 68:239-45. 2005
  4. doi request reprint Intraoperative ultrasound with contrast medium in resective pancreatic surgery: a pilot study
    Antonino Spinelli
    Unità Operativa e Cattedra di Chirurgia Generale, Universita degli Studi di Milano, Istituto Clinico Humanitas IRCCS, Via Alessandro Manzoni 56, 20089, Rozzano, Milan, Italy
    World J Surg 35:2521-7. 2011
  5. doi request reprint Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial
    Marco Montorsi
    Department of General Surgery, University of Milan, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, Rozzano, Milan, Italy
    Ann Surg 256:853-9; discussion 859-60. 2012
  6. doi request reprint Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases
    Alessandro Zerbi
    Department of Surgery, Pancreas Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Gastroenterol 105:1421-9. 2010
  7. doi request reprint Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma
    Michele Reni
    Department of Oncology, S Raffaele Scientific Institute, Milan, Italy
    Cancer 115:2630-9. 2009
  8. doi request reprint Extending indications for islet autotransplantation in pancreatic surgery
    Gianpaolo Balzano
    Department of Surgery, San Raffaele Scientific Institute, Milan, Italy
    Ann Surg 258:210-8. 2013
  9. doi request reprint Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital
    Nicolò Pecorelli
    Department of Surgery, San Raffaele Hospital, Vita Salute San Raffaele University, Via Olgettina 60, 20132, Milan, Italy
    J Gastrointest Surg 16:518-23. 2012
  10. doi request reprint The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma
    Federica Marchesi
    Department of Immunology and Inflammation, IRCCS Clinical Institute Humanitas, Rozzano, Milano, Italy
    Cancer Res 68:9060-9. 2008

Collaborators

Detail Information

Publications19

  1. doi request reprint Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases
    Alessandro Zerbi
    Pancreatic Surgery Section, Humanitas Scientific Institute, Via Manzoni 56, Rozzano, Milan, Italy
    Langenbecks Arch Surg 396:313-21. 2011
    ..Information on the treatment of pancreatic endocrine tumours (PETs) comes mostly from small, retrospective, uncontrolled studies...
  2. doi request reprint Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial
    Michele Reni
    Department of Oncology, S Raffaele Scientific Institute, Milan, Italy
    Ann Surg Oncol 19:2256-63. 2012
    ..This randomized phase II trial aimed to identify the most promising regimen warranting phase III evaluation...
  3. ncbi request reprint Final results of a prospective trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) regimen followed by radiotherapy after curative surgery for pancreatic adenocarcinoma
    Michele Reni
    Department of Radiochemotherapy, S Raffaele H Scientific Institute, Milan, Italy
    Oncology 68:239-45. 2005
    ..Postoperative management of patients with pancreatic adenocarcinoma (PA) is controversial...
  4. doi request reprint Intraoperative ultrasound with contrast medium in resective pancreatic surgery: a pilot study
    Antonino Spinelli
    Unità Operativa e Cattedra di Chirurgia Generale, Universita degli Studi di Milano, Istituto Clinico Humanitas IRCCS, Via Alessandro Manzoni 56, 20089, Rozzano, Milan, Italy
    World J Surg 35:2521-7. 2011
    ..The purpose of the present study was to prospectively evaluate the possible role of contrast-enhanced intraoperative ultrasound (CEIOUS) during resective pancreatic surgery for primary lesion characterization and intraoperative staging...
  5. doi request reprint Efficacy of an absorbable fibrin sealant patch (TachoSil) after distal pancreatectomy: a multicenter, randomized, controlled trial
    Marco Montorsi
    Department of General Surgery, University of Milan, Istituto Clinico Humanitas IRCCS, Via Manzoni 56, Rozzano, Milan, Italy
    Ann Surg 256:853-9; discussion 859-60. 2012
    ..To evaluate the role of an absorbable fibrin sealant patch (TachoSil) in reducing postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP)...
  6. doi request reprint Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases
    Alessandro Zerbi
    Department of Surgery, Pancreas Unit, San Raffaele Scientific Institute, Milan, Italy
    Am J Gastroenterol 105:1421-9. 2010
    ..The aim of the study was to describe the clinical and pathological features of PETs in a prospective, multicenter study...
  7. doi request reprint Carbohydrate antigen 19-9 change during chemotherapy for advanced pancreatic adenocarcinoma
    Michele Reni
    Department of Oncology, S Raffaele Scientific Institute, Milan, Italy
    Cancer 115:2630-9. 2009
    ..The objective of this study was to evaluate the correlation between a decline in carbohydrate antigen 19-9 (CA 19-9) and survival in patients with advanced pancreatic cancer who received upfront chemotherapy...
  8. doi request reprint Extending indications for islet autotransplantation in pancreatic surgery
    Gianpaolo Balzano
    Department of Surgery, San Raffaele Scientific Institute, Milan, Italy
    Ann Surg 258:210-8. 2013
    ..To assess metabolic and oncologic outcomes of islet autotransplantation (IAT) in patients undergoing pancreatic surgery for either benign or malignant disease...
  9. doi request reprint Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital
    Nicolò Pecorelli
    Department of Surgery, San Raffaele Hospital, Vita Salute San Raffaele University, Via Olgettina 60, 20132, Milan, Italy
    J Gastrointest Surg 16:518-23. 2012
    ..The aim of this study is to assess the independent impact of surgeon volume on outcome after PD in a single high-volume institution...
  10. doi request reprint The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma
    Federica Marchesi
    Department of Immunology and Inflammation, IRCCS Clinical Institute Humanitas, Rozzano, Milano, Italy
    Cancer Res 68:9060-9. 2008
    ..Thus, the CX3CR1-CX3CL1 axis could represent a valuable therapeutic target to prevent tumor perineural dissemination in pancreatic cancer...
  11. pmc Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma
    Luigi Laghi
    Laboratory of Molecular Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
    PLoS ONE 7:e46002. 2012
    ..Aims of the study were to determine the prevalence of MSI in surgically resected pancreatic cancers in a multicentric, retrospective study, and to assess the occurrence of pancreatic cancer in LS...
  12. doi request reprint Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection?
    Alessandro Zerbi
    Pancreas Unit, Department of Surgery, S Raffaele Scientific Institute, V Olgettina 60, 20132, Milan, Italy
    Ann Surg Oncol 15:1161-8. 2008
    ..Pancreas is a possible site of metastases from renal cell carcinoma (RCC). The aim of this study was to define the role of surgery in their treatment...
  13. ncbi request reprint Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
    Federica Marchesi
    Department of Immunology and Cell Biology, Mario Negri Institute, Milan, Italy
    Cancer Res 64:8420-7. 2004
    ..CXCR4 not only stimulates cell motility and invasion but also promotes survival and proliferation. Strategies to target CXCR4 expressed on tumor cells may be of benefit in patients with pancreatic cancer...
  14. ncbi request reprint Intraductal papillary mucinous tumors of the pancreas: incidence, clinical findings and natural history
    Gianpaolo Balzano
    Pancreas Unit, Department of Surgery, S Raffaele Hospital, Milan, Italy
    JOP 6:108-11. 2005
  15. pmc Surgical management of acute pancreatitis in Italy: lessons from a prospective multicentre study
    Paolo De Rai
    Department of Surgery and Emergency Surgery, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Institute for Scientific Care and Treatment Ca Granda Ospedale Maggiore Policlinico, Milan, Italy
    HPB (Oxford) 12:597-604. 2010
    ..This study aimed to evaluate the surgical treatment of acute pancreatitis in Italy and to assess compliance with international guidelines...
  16. ncbi request reprint Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
    Michele Reni
    Department of Radiochemotherapy, S Raffaele H Scientific Institute, Milan, Italy
    Lancet Oncol 6:369-76. 2005
    ..We aimed to assess whether a four-drug regimen could improve 4 month progression-free survival compared with gemcitabine alone...
  17. ncbi request reprint Double self-expandable total-coated metal stent for gastrojejunal leak after pancreatoduodenectomy
    Enzo Masci
    Division of Gastroenterology and Gastrointestinal Endoscopy, Vita Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy
    Gastrointest Endosc 66:1024-5. 2007
  18. ncbi request reprint Strategies for tumor immune escape
    Lorenzo Piemonti
    Laboratory of Experimental Surgery, Department of Surgery II, Fondazione Centro S Raffaele del Monte Tabor, Milan, Italy
    Drugs Today (Barc) 39:701-24. 2003
    ..The purpose of this review is to evaluate the current status of knowledge concerning these different tumor-escape strategies...
  19. ncbi request reprint Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers
    Luigi Laghi
    Division of Gastroenterology, Istituto Clinico Humanitas, Rozzano, Milan, 20089 Italy
    Oncogene 21:4301-6. 2002
    ..Results show that multiple K-RAS mutations are frequent both in PC with associated PanIN and in biliary cancers, and indicate that clonally distinct precursor lesions of PC might variably contribute to tumor development...